Chemoinformaics analysis of 2,4,6-Heptanetrione
| Molecular Weight | 142.154 | nRot | 4 |
| Heavy Atom Molecular Weight | 132.074 | nRig | 3 |
| Exact Molecular Weight | 142.063 | nRing | 0 |
| Solubility: LogS | -0.493 | nHRing | 0 |
| Solubility: LogP | -0.521 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 20 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 7 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 20.7639 |
| nHD | 0 | BPOL | 12.6361 |
| QED | 0.537 |
| Synth | 2.459 |
| Natural Product Likeliness | 0.776 |
| NR-PPAR-gamma | 0.282 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.335 |
| Pgp-sub | 0.964 |
| HIA | 0.008 |
| CACO-2 | -4.926 |
| MDCK | 0.000019 |
| BBB | 0.439 |
| PPB | 0.380918 |
| VDSS | 0.389 |
| FU | 0.818962 |
| CYP1A2-inh | 0.013 |
| CYP1A2-sub | 0.358 |
| CYP2c19-inh | 0.026 |
| CYP2c19-sub | 0.274 |
| CYP2c9-inh | 0.011 |
| CYP2c9-sub | 0.616 |
| CYP2d6-inh | 0.002 |
| CYP2d6-sub | 0.248 |
| CYP3a4-inh | 0.007 |
| CYP3a4-sub | 0.272 |
| CL | 5.3 |
| T12 | 0.93 |
| hERG | 0.089 |
| Ames | 0.057 |
| ROA | 0.645 |
| SkinSen | 0.936 |
| Carcinogencity | 0.017 |
| EI | 0.962 |
| Respiratory | 0.982 |
| NR-Aromatase | 0.005 |
| Antiviral | No |
| Prediction | 0.941151 |